Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
leading, global full-service clinical research organization, today announced
Boston Fall Investors Conference. The conference will be held at The State
Room, 60 State Street, 33rd floor, in
presentation is scheduled from
Presentations will not be webcast at the conference. However, slides from
Kendle’s presentation will be available by
Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical
research organization providing the full range of early- to late-stage
clinical development services for the world’s biopharmaceutical industry. Our
focus is on innovative solutions that reduce cycle times for our customers and
accelerate the delivery of life-enhancing drugs to market for the benefit of
patients worldwide. As one of the fastest-growing global providers of Phase
I-IV services, we offer experience spanning 90 countries, along with
industry-leading patient access and retention capabilities and broad
therapeutic expertise, to meet our customers’ clinical development challenges.
Kendle was recognized by FORTUNE magazine as one of the 100
fastest-growing companies in
been recognized as “Top CRO to Work With” in the CenterWatch 2007 survey of
U.S. investigative sites and “Best CRO” for 2007 and 2006 by leading global
pharmaceutical publication Scrip World Pharmaceutical News.
Additional information and investor kits are available upon request from
Kendle, 441 Vine Street, Suite 1200,
Company’s Web site at http://www.kendle.com .
SOURCE Kendle International Inc.